Company* (Country; Symbol) |
Company* |
Type/Product Area |
Terms/Details (Date) |
| |||
Accelrys Inc. (subsidiary of Pharmacopeia Inc.; PCOP) |
IBM Corp. and |
Agreement to support a global research effort focused on the development of new drugs to combat the smallpox virus post infection |
The project will be powered through a computing grid that will be designed to enable computer owners worldwide to contribute idle computing resources with the goal of developing a collection of potential anti-smallpox drugs (2/5) |
|
|
||
Biogen Inc. |
Phase |
Three-year technology subscription for Phase Forward's InForm electronic data capture solution |
Biogen will use the technology to expedite the collection and management of trial data (1/15) |
|
|||
Chiron Corp. (CHIR) |
Axeda Systems Inc. |
Licensing agreement for the Axeda DRM System to enable the proactive monitoring, service and support of Chiron's Procleix System |
Chiron will use the Axeda DRM system to remotely monitor Procleix Instrumentation installed at customer facilities, designed to improve service response times and instrument uptimes of those medical instruments (1/7) |
|
|||
DeCode genetics Inc. (Ireland; DCGN) |
IBM Corp. |
Three-year alliance to jointly market a set of integrated applications, technologies and services for analyzing, managing and storing genetic, genealogical and clinical data |
The companies will market and sell DeCode's Clinical Genome Miner Discovery system running on IBM hardware and software (1/23) |
|
|||
Iconix Pharmaceuticals Inc.* |
MDL Information Systems Inc. |
Agreement for Iconix to link its DrugMatrix with the ISIS Enterprise Edition of MDL |
The pairing is designed to provide subscribers access to the genomic, chemical, toxicology and pharmacology information in Iconix's database by using all of the ISIS structure-searching tools (1/14) |
|
|||
Plexxikon Inc.* |
Synthematix Inc. |
Agreement to incorporate into Plexxikon's drug discovery platform the Arthur technology belonging to Synthematix |
Plexxikon gains access to Synthematix's Arthur family of products consisting of two major components: a database of synthetic organic reactions and experimental conditions combined with a search engine, and a suite of modules to enter, analogue, annotate and mine the database (1/15) |
|
|||
SurroMed Inc.* |
Fidelity Biosciences Group* |
Agreement to develop biomarkers and diagnostic products for neurodegenerative conditions |
Fidelity will provide SurroMed multiyear funding to develop the biomarkers as well as to conduct preclinical and clinical studies; SurroMed will share in the commercialization of any resulting biomarkers (2/10) |
|
|||
Zen-Bio Inc.* |
Linco Diagnostic Services Inc. |
Joint contract assay service agreement for monitoring the release of cytokines and endocrine analytes from human adipocytes and preadipocytes |
The service takes advantage of LINCOplex assays offered by Linco Diagnostics and the cultured human adipocyte model offered by Zen-Bio (1/16) |
| |||
Notes: | |||
# This chart does not include agreements that involve agricultural product development. | |||
* Private companies are indicated with an asterisk | |||
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. |